Moolec Science (MLEC) Non Operating Income (2022 - 2024)
Moolec Science's (MLEC) quarterly Non Operating Income came in at $2.6 million in Q4 2024, up 638.91% year-on-year from $357000.0 in Q1 2024, and up 1988.71% quarter-over-quarter from -$139667.0 in Q3 2024.
Moolec Science (MLEC) Non Operating Income (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Non Operating Income across 3 years of filings, most recently posting $2.6 million for Q4 2024.
- Non Operating Income for Q4 2024 came in at $2.6 million, up 638.91% year-over-year; the trailing twelve-month figure through Dec 2024 was $2.1 million (up 212.32% YoY), and the FY2024 annual result was -$983959.0, up 32.28% from the prior year.
- Non Operating Income came in at $2.6 million for Q4 2024 at Moolec Science, up from -$139667.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.6 million in Q4 2024 to a low of -$1.4 million in Q2 2023.
- The 3-year median for Non Operating Income is $1428.0 (2022), against an average of -$34225.0.
- Peak annual rise in Non Operating Income reached 915284.62% in 2023, while the deepest fall reached 48729.93% in 2023.
- Moolec Science's Non Operating Income stood at $39.0 in 2022, then surged by 915284.62% to $357000.0 in 2023, then surged by 638.91% to $2.6 million in 2024.
- The last three Non Operating Income figures came in at $2.6 million (Q4 2024), -$139667.0 (Q3 2024), and $348090.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 9.35 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.64 Mn |
| Sep 30, 2024 | -139,667.00 |
| Jun 30, 2024 | 348,090.00 |
| Mar 31, 2024 | -745,466.00 |
| Dec 31, 2023 | 357,000.00 |
| Sep 30, 2023 | -943,583.00 |
| Jun 30, 2023 | -1.37 Mn |
| Mar 31, 2023 | 86,119.00 |
| Dec 31, 2022 | 39.00 |
| Sep 30, 2022 | 3,110.00 |
| Jun 30, 2022 | 2,817.00 |
| Mar 31, 2022 | -647,165.00 |